Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest.

We’re moving fast! Longevity 2020 started just over 2 weeks ago and it looks like, together with a stellar group of speakers, we’re creating an exciting new approach to sharing ideas in our growing Longevity community.

Our team is currently curating the agendas for each day and we plan to share these with you shortly: then we’ll switch ticketing to live.

As a reminder, all presentation content is FREE so do please encourage your colleagues and people in your network to pre-register – we have over 350 pre-registrations already: thanks for your support!

Here’s a reminder of what’s happening over a very big week for Longevity:

Phil Newman
Editor-in-Chief Phil has over 25 years of C-level management, marketing and business development expertise in Europe and North America. His creative background has helped him shape unconventional strategies for commercial growth - garnering both awards and investor ROI.

Phil has wide experience of technology transfer and the commercialisation of innovations from both private and institutional sources and this led to his interest in Longevity and the founding of Longevity.Technology.

Latest articles

Fountain’s ‘hypothesis-free’ approach to Longevity AI

We reached out to Fountain’s CEO John Dimos to see what more we can learn about the mysterious San Francisco start-up. When it comes to...

G3 and Juvenescence partner on deep learning venture

G3 Therapeutics and Juvenescence announce the formation of Juvenomics to apply deep molecular profiling and deep learning to tackle aging. Juvenomics, a joint venture between...

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.